Last 48 quarters of trend data · Financial Services · Financial - Data & Stock Exchanges
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
CME Group Inc.'s quarterly P/E stands at 23.2x, down 8.3% year-over-year.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 25.70 | 23.22 | 21.07 | 27.13 | 24.52 | 25.31 | 24.19 | 22.07 | 20.31 | 22.90 | 23.50 | 24.30 | 21.65 |
| — | -8.3% | -12.9% | +22.9% | +20.7% | +10.5% | +2.9% | -9.2% | -6.2% | +16.2% | -2.2% | +3.7% | -23.0% | |
| P/S Ratio | 15.96 | 14.26 | 14.92 | 15.83 | 14.67 | 14.55 | 13.70 | 12.53 | 11.54 | 13.02 | 13.16 | 13.46 | 12.24 |
| — | -2.0% | +8.8% | +26.3% | +27.1% | +11.8% | +4.2% | -6.9% | -5.7% | +9.1% | +5.2% | +3.8% | -17.6% | |
| P/B Ratio | 3.60 | 4.03 | 3.42 | 3.45 | 3.58 | 3.54 | 3.16 | 2.82 | 2.56 | 2.85 | 2.83 | 2.56 | 2.39 |
| — | +14.0% | +8.5% | +22.7% | +39.8% | +23.9% | +11.4% | +10.1% | +6.9% | +13.5% | +26.1% | +13.5% | -8.8% | |
| P/FCF | 24.81 | 21.28 | 22.33 | 25.63 | 23.87 | 21.67 | 21.08 | 20.40 | 23.31 | 22.19 | 18.50 | 21.51 | 26.43 |
| — | -1.8% | +5.9% | +25.6% | +2.4% | -2.3% | +13.9% | -5.1% | -11.8% | +14.4% | +17.3% | -14.3% | -13.8% | |
| EV / EBITDA | 22.95 | 20.25 | 23.35 | 23.30 | 20.77 | 20.49 | 20.41 | 18.17 | 16.68 | 19.01 | 20.08 | 20.12 | 18.36 |
| — | -1.2% | +14.4% | +28.2% | +24.5% | +7.8% | +1.7% | -9.7% | -9.1% | +7.8% | -0.3% | +2.7% | -17.9% | |
| EV / EBIT | 24.45 | 20.67 | 15.62 | 20.13 | 18.33 | 18.96 | 18.50 | 16.54 | 15.15 | 17.22 | 18.23 | 18.03 | 16.12 |
| — | +9.0% | -15.5% | +21.7% | +21.0% | +10.1% | +1.5% | -8.3% | -6.0% | +16.6% | +3.5% | +2.2% | -22.1% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
CME Group Inc.'s operating margin was 69.7% in Q1 2026, up 7.8 pp QoQ and up 2.2 pp YoY. The trailing four-quarter average of 65.4% lags the current quarter, suggesting the recent improvement is above-trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.1% | 88.1% | 85.4% | 84.5% | 86.9% | 87.4% | 85.5% | 86.2% | 86.6% | 86.2% | 85.2% | 84.6% | 84.9% |
| — | +0.8% | -0.2% | -1.9% | +0.3% | +1.5% | +0.4% | +1.8% | +2.1% | +0.4% | +1.4% | +0.1% | -0.2% | |
| Operating Margin | 64.9% | 69.7% | 61.8% | 63.3% | 66.7% | 67.5% | 62.1% | 64.6% | 65.3% | 64.5% | 60.0% | 61.3% | 61.7% |
| — | +3.3% | -0.4% | -2.1% | +2.2% | +4.6% | +3.5% | +5.4% | +5.9% | +1.8% | +8.4% | +1.9% | +1.7% | |
| Net Margin | 62.0% | 61.4% | 70.8% | 59.1% | 59.8% | 58.2% | 57.3% | 57.6% | 57.6% | 57.5% | 56.6% | 56.1% | 57.2% |
| — | +5.4% | +23.6% | +2.5% | +3.8% | +1.3% | +1.3% | +2.7% | +0.8% | -6.2% | +7.2% | +1.3% | +6.8% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 14.6% | 4.2% | 4.1% | 3.2% | 3.7% | 3.6% | 3.2% | 3.3% | 3.2% | 3.2% | 3.0% | 2.7% | 2.8% |
| — | +16.7% | +28.3% | -0.7% | +14.6% | +12.6% | +7.7% | +21.9% | +14.4% | -2.6% | +28.3% | +11.0% | +18.5% | |
| ROA | 2.4% | 0.6% | 0.6% | 0.5% | 0.6% | 0.6% | 0.6% | 0.7% | 0.7% | 0.7% | 0.6% | 0.5% | 0.5% |
| — | -11.0% | -4.7% | -29.2% | -13.3% | -0.9% | -0.4% | +29.0% | +41.1% | +25.8% | +76.4% | +41.6% | +41.5% | |
| ROIC | 10.2% | 3.1% | 2.4% | 2.3% | 2.7% | 2.8% | 2.3% | 2.5% | 2.4% | 2.4% | 2.1% | 2.0% | 2.0% |
| — | +14.1% | +3.4% | -5.1% | +12.9% | +16.2% | +10.0% | +25.1% | +20.1% | +5.7% | +29.7% | +11.6% | +12.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
CME Group Inc.'s Debt/EBITDA ratio is 2.6x, down from 3.6x last quarter — at a moderate level that warrants monitoring.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.13 | 0.13 | 0.13 | 0.12 | 0.12 | 0.13 | 0.13 | 0.12 | 0.12 | 0.13 | 0.13 | 0.12 | 0.12 |
| — | +1.7% | +1.1% | -0.1% | -0.6% | +0.3% | +1.0% | -0.2% | +0.7% | +0.5% | +0.1% | +0.0% | +0.3% | |
| Debt / EBITDA | 0.83 | 2.56 | 3.59 | 3.24 | 2.82 | 2.87 | 3.33 | 3.09 | 3.16 | 3.28 | 3.61 | 3.77 | 3.69 |
| — | -10.9% | +8.0% | +4.8% | -10.7% | -12.4% | -7.8% | -17.9% | -14.4% | -4.4% | -20.4% | -9.1% | -9.8% | |
| Current Ratio | 92.97 | 1.02 | 92.97 | 1.02 | 1.02 | 1.02 | 1.01 | 1.02 | 1.02 | 1.01 | 1.02 | 1.03 | 1.02 |
| — | +0.1% | +9131.8% | -0.2% | -0.2% | +0.4% | -0.9% | -1.0% | -0.1% | -0.3% | +0.6% | +1.4% | +0.4% | |
| Quick Ratio | 92.97 | 1.02 | 92.97 | 1.02 | 1.02 | 1.02 | 1.01 | 1.02 | 1.02 | 1.01 | 1.02 | 1.03 | 1.02 |
| — | +0.1% | +9131.8% | -0.2% | -0.2% | +0.4% | -0.9% | -1.0% | -0.1% | -0.3% | +0.6% | +1.4% | +0.4% | |
| Interest Coverage | 41.98 | 30.04 | — | 27.75 | 31.23 | 30.85 | 27.94 | 30.28 | 29.79 | 28.90 | 26.34 | 25.60 | 26.28 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying CME stock.
CME Group Inc.'s current P/E is 25.7x. The average P/E over the last 4 quarters is 24.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
CME Group Inc.'s current operating margin is 64.9%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking CME Group Inc.'s business trajectory between earnings reports.